Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor MacLaren awarded 2013 ARVO Vision Foundation Pfizer Ophthalmics Carl Camras Translational Research Award

Professor MacLaren
Professor MacLaren

Robert MacLaren, Professor of Ophthalmology in the Nuffield Department of Clinical Neurosciences and Consultant Ophthalmologist at the Oxford Eye Hospital has won a 2013 Pfizer Ophthalmics Carl Camras Translational Research Award. Presented by the ARVO Vision Foundation, these prestigious international awards are made annually to researchers under 45 who have exhibited excellence in research, fundamental scientific discoveries, concepts and novel technologies likely to lead to clinical benefits. Robert was recognized for is pioneering research into novel treatments for retinal degeneration. His clinical and clinically relevant research achievements include successful mammalian optic nerve regeneration; first UK retinal transplantation trial for macular degeneration; his 2006 Nature paper showing retinal repair by transplantation of photoreceptor precursors is one of the journals top-10 downloads; and he was named one of the Medical Research Council’s leading scientists. He has recently successfully initiated, as chief investigator, the world’s first multicentre retinal gene therapy trial for choroideraemia.

Visit Professor MacLaren’s webpage 

Similar stories

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

NDCN Thomas Willis Day Prize Winners

Our annual Thomas Willis Day celebrates the work of our Department over the previous year.